{
event: "article_read",
name: `Pneumology Meets Oto-Rhino-Laryngology: A Discussion of Type 2 Inflammation in Airway Diseases`,
author: ``,
tags: `Nasal Polyps`,
publication_date: ``,
interaction_type: "content"
}
Read article
Pneumology Meets Oto-Rhino-Laryngology: A Discussion of Type 2 Inflammation in Airway Diseases
Present evidence from clinical trials and real-world experience to demonstrate the safety and efficacy of Dupilumab, a biologic targeting the key and central cytokines of Type 2 inflammation, in both upper and lower airway diseases.
.png/jcr:content/image%20(94).png)
Related articles
.png/jcr:content/2%20(3).png)
.png0/jcr:content/3%20(2).png)
Hear From An Expert On Would You Consider A Biologic For A Surgery-Naïve Patient With Crs With Nasal Polyps?
MAT-BH-2300373/V1/JUNE 2023